Daniel, Lisel L.

HRN: 27-09-38  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
CEFUROXIME 1.5GM (VIAL)
08/31/2025
09/06/2025
IV
1.5g
Q8
Internal Hemorrhoids, Gr.4 For Elective OR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines